Replies to post #774199 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Atl has been wrong a lot and just can't face facts

That's right—just as many other cult members have blindly dismissed critical issues. The DCVax-L trial is far from a slam dunk, primarily due to the lack of regulatory authority (RA) guidance on the use of external control arms (ECA) and real-world evidence (RWE) without access to individual patient data (IPD). That’s a major problem.

We should count ourselves lucky that the MHRA now appears willing to accommodate NWBO by initiating guidance, likely to create a framework that would allow DCVax-L to be approved. But let’s be clear: this has been a massive gamble, on top of the already speculative nature of biotech investing.

Unfortunately, there are very few voices on this board who demonstrate real understanding of regulatory affairs. And the cult-like enthusiasts are certainly not among them.

[ATLnsider]

Hopeforthefuture3, if you or dennisdave have some verifiable links that prove that I am wrong, please post them here for all to see, and so that I can check them out.

If you post some verifiable links from reputable sources, that refute what I am saying, I will gladly say I am wrong, and I will change my views.

But, until then, I will stick with the FDA’s guidance and the words of Dr. Linda Liau and the words coming from NWBio.

[Investor082]

He/She is a well known pumper, just like Zivic, and others!

He/She was pumping project Orbis and worldwide regulatory & reimbursement approval for DCVAX-L about 4 years ago and continued to do so for many months. Similarly, his/her claims about hundreds of thousands of shares purchased over $1, and last chance to purchase under $1 were all classics from a few years ago. There’s likely a lot more of such lies from before data lock days too! ;)

Although, one thing that never fails is stock price always goes down whenever ATL starts posting on social media and more so when he/she claims they purchased more NWBO shares, LOL!